Hot Pursuit     22-Feb-22
Alembic Pharmaceuticals Ltd eases for fifth straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 687.5, down 0.64% on the day as on 13:24 IST on the NSE. The stock tumbled 22.95% in last one year as compared to a 15.16% rally in NIFTY and a 6.28% spurt in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 687.5, down 0.64% on the day as on 13:24 IST on the NSE. The benchmark NIFTY is down around 1.56% on the day, quoting at 16937.8. The Sensex is at 56792.03, down 1.55%.Alembic Pharmaceuticals Ltd has eased around 9.06% in last one month.Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has eased around 1.64% in last one month and is currently quoting at 13029.9, down 1.88% on the day. The volume in the stock stood at 1.74 lakh shares today, compared to the daily average of 2.68 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 690.45, down 0.37% on the day. Alembic Pharmaceuticals Ltd tumbled 22.95% in last one year as compared to a 15.16% rally in NIFTY and a 6.28% spurt in the Nifty Pharma index.

The PE of the stock is 17.58 based on TTM earnings ending December 21.

Previous News
  Alembic receives USFDA approval for Fesoterodine Fumarate ER Tablets
 ( Corporate News - 06-Jan-23   11:03 )
  Alembic Pharm gets US FDA approvals for five products in Q1 FY24
 ( Hot Pursuit - 03-Jul-23   09:54 )
  Volumes jump at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 21-Feb-23   11:00 )
  Alembic Pharma gets USFDA nod for osteoarthritis drug
 ( Hot Pursuit - 01-Dec-22   11:44 )
  Alembic Pharmaceuticals gets USFDA approval
 ( Corporate News - 27-Oct-22   11:52 )
  Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
 ( Hot Pursuit - 09-Mar-23   09:18 )
  Alembic Pharma gets USFDA final approval for Fesoterodine Fumarate
 ( Hot Pursuit - 06-Jan-23   10:59 )
  Alembic receives USFDA approval for Diclofenac Sodium Topical Solution
 ( Corporate News - 01-Dec-22   11:17 )
  Alembic Pharmaceuticals gets USFDA nod for hypertension drug
 ( Hot Pursuit - 29-Aug-22   11:59 )
  Alembic Pharmaceuticals reports consolidated net loss of Rs 65.88 crore in the June 2022 quarter
 ( Results - Announcements 04-Aug-22   17:27 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Brexpiprazole Tablets
 ( Corporate News - 09-Mar-23   10:39 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top